State of New Jersey Common Pension Fund D lowered its stake in Colgate-Palmolive (NYSE:CL) by 2.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,014,000 shares of the company’s stock after selling 30,000 shares during the period. State of New Jersey Common Pension Fund D owned 0.12% of Colgate-Palmolive worth $73,870,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Blue Chip Partners Inc. boosted its position in Colgate-Palmolive by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after buying an additional 8 shares in the last quarter. Cue Financial Group Inc. boosted its position in Colgate-Palmolive by 0.3% in the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after buying an additional 14 shares in the last quarter. AlphaMark Advisors LLC boosted its position in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares in the last quarter. Capital Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 0.3% during the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after purchasing an additional 27 shares during the period. Finally, Weatherstone Capital Management lifted its holdings in shares of Colgate-Palmolive by 0.7% during the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares during the period. Hedge funds and other institutional investors own 72.84% of the company’s stock.

In related news, insider Victoria L. Dolan sold 10,000 shares of Colgate-Palmolive stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the transaction, the insider now owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders have sold 181,048 shares of company stock valued at $13,168,995 in the last three months. 1.02% of the stock is owned by insiders.

A number of equities analysts have recently commented on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday. Jefferies Group reiterated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a report on Thursday, September 28th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a report on Tuesday. Royal Bank of Canada reiterated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, Citigroup cut their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. Three analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $76.33.

Colgate-Palmolive (NYSE CL) opened at $74.85 on Wednesday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The firm has a market cap of $64,971.00, a price-to-earnings ratio of 25.78, a P/E/G ratio of 3.39 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the firm earned $0.73 earnings per share. Colgate-Palmolive’s quarterly revenue was up 2.8% on a year-over-year basis. analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

WARNING: “State of New Jersey Common Pension Fund D Has $73.87 Million Position in Colgate-Palmolive (CL)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/state-of-new-jersey-common-pension-fund-d-has-73-87-million-position-in-colgate-palmolive-cl/1774076.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.